These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. [Development of new therapy on muscular dystrophy]. Takeda S Rinsho Shinkeigaku; 2001 Dec; 41(12):1154-6. PubMed ID: 12235824 [TBL] [Abstract][Full Text] [Related]
68. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy. Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351 [TBL] [Abstract][Full Text] [Related]
69. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene. Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA Neuromuscul Disord; 2006 Mar; 16(3):192-203. PubMed ID: 16487708 [TBL] [Abstract][Full Text] [Related]
70. sPIF promotes myoblast differentiation and utrophin expression while inhibiting fibrosis in Duchenne muscular dystrophy via the H19/miR-675/let-7 and miR-21 pathways. Morgoulis D; Berenstein P; Cazacu S; Kazimirsky G; Dori A; Barnea ER; Brodie C Cell Death Dis; 2019 Jan; 10(2):82. PubMed ID: 30692507 [TBL] [Abstract][Full Text] [Related]
71. Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy. Mitchell R; Frederick NE; Holzman ER; Agobe F; Allaway HCM; Bagher P Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H52-H58. PubMed ID: 34048282 [TBL] [Abstract][Full Text] [Related]
72. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Nguyen HH; Jayasinha V; Xia B; Hoyte K; Martin PT Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5616-21. PubMed ID: 11960016 [TBL] [Abstract][Full Text] [Related]
73. Multiple regulatory events controlling the expression and localization of utrophin in skeletal muscle fibers: insights into a therapeutic strategy for Duchenne muscular dystrophy. Jasmin BJ; Angus LM; Bélanger G; Chakkalakal JV; Gramolini AO; Lunde JA; Stocksley MA; Thompson J J Physiol Paris; 2002; 96(1-2):31-42. PubMed ID: 11755781 [TBL] [Abstract][Full Text] [Related]
75. Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD? Wells DJ; Wells KE Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S11-22. PubMed ID: 12206790 [TBL] [Abstract][Full Text] [Related]
77. Expression of the dystrophin-related protein (utrophin) gene during mouse embryogenesis. Schofield J; Houzelstein D; Davies K; Buckingham M; Edwards YH Dev Dyn; 1993 Dec; 198(4):254-64. PubMed ID: 8130373 [TBL] [Abstract][Full Text] [Related]
78. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518 [TBL] [Abstract][Full Text] [Related]
79. Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the Potter RA; Griffin DA; Heller KN; Peterson EL; Clark EK; Mendell JR; Rodino-Klapac LR Hum Gene Ther; 2021 Apr; 32(7-8):375-389. PubMed ID: 33397205 [TBL] [Abstract][Full Text] [Related]
80. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies. Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]